Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.200
+0.010 (0.84%)
Dec 20, 2024, 4:00 PM EST - Market closed
Clearmind Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 |
| Market Capitalization | 5 | 2 | 10 | 22 | - | - | |
| Market Cap Growth | 75.47% | -82.89% | -53.14% | - | - | - | |
| Enterprise Value | -3 | -2 | 10 | 17 | - | - | |
| Last Close Price | 1.20 | 3.66 | 237.00 | 533.61 | - | - | |
| PB Ratio | 1.37 | 1.81 | -9.43 | 4.63 | - | - | |
| P/TBV Ratio | 1.63 | 2.06 | - | 4.83 | - | - | |
| Debt / Equity Ratio | 0.02 | - | -0.03 | - | - | - | |
| Quick Ratio | 1.68 | 1.16 | 0.22 | 13.33 | 24.92 | 0.08 | |
| Current Ratio | 1.71 | 1.17 | 0.22 | 13.78 | 24.92 | 0.08 | |
| Return on Equity (ROE) | -267.90% | - | -570.96% | -145.26% | -182.13% | -56.47% | |
| Return on Assets (ROA) | -57.95% | -116.22% | -169.53% | -83.90% | -100.94% | -25.29% | |
| Return on Capital (ROIC) | -115.35% | - | -318.49% | -89.97% | -113.83% | -28.83% | |
| Earnings Yield | -173.39% | -483.16% | -66.13% | -16.72% | - | - | |
| FCF Yield | -93.16% | -353.17% | -35.78% | -12.89% | - | - | |
| Buyback Yield / Dilution | -1696.41% | -367.25% | -40.19% | -70.50% | -47.00% | -14.42% | |
| Total Shareholder Return | -1696.41% | -367.25% | -40.19% | -70.50% | -47.00% | -14.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.